(Q36388371)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Asmita Mishra

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Maria Corrales-Yepez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Najla Al Ali

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Mohamed Kharfan-Dabaja

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Eric Padron

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ling Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Pearlie K Epling-Burnette

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Javier Pinilla-Ibarz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jeffrey E Lancet

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Rami S Komrokji

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

30 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Hematology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

566-570

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

Revised international prognostic scoring system for myelodysplastic syndromes

29 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685468

Clinical effect of point mutations in myelodysplastic syndromes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685468

Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685468

Myelodysplastic syndromes classification and risk stratification

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685468

Therapy-related myeloid neoplasms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685468

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685468

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685468

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685468

International scoring system for evaluating prognosis in myelodysplastic syndromes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4685468

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

30 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FAJH.23454

Risk assessment in chronic myelomonocytic leukemia (CMML).

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FAJH.23454

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23605934

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23605934

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/AJH.23454

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605934%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

23605934

1 reference